Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by THORNE, P. S.
Right arrow Articles by GUINEY, P. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by THORNE, P. S.
Right arrow Articles by GUINEY, P. D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1991 Oxford University Press

research-article

The Noninvasive Mouse Ear Swelling Assay

I. Refinements for Detecting Weak Contact Sensitizers

PETER S. THORNE*,1, CHERYL HAWK*, SUSAN D. KALISZEWSKI* and PATRICK D. GUINEY{dagger}

*Department of Preventive Medicine and Environmental Health, College of Medicine. University of Iowa Iowa City, Iowa 52242 {dagger}S. C. Johnson & Son, Inc. Racine, Wisconsin

Received January 23, 1991; accepted June 4, 1991

The Noninvasive Mouse Ear Swelling Assay. I. Refinements for Detecting Weak Contact Sensitizers. THORNE, P. S., HAWK, C, KAUSZEWSKI, S. D., AND GUINEY, P. D. (1991). Fundam. Appl. Toxicol. 17, 790–806. The noninvasive mouse ear swelling assay (MESA) is a model for delayed-type hypersensitivity that holds promise as a testing protocol for allergic contact dermatitis (ACD). The MESA employs only topical sensitization on the abdomen and does not use injections, adjuvants, anesthesia, occlusion, or disruption of the stratum comeum. Five days after induction, the ears are challenged topically and ear swelling measurements taken at 24,48, and 72 hr indicate the extent of ACD. In this study, refinements of the assay were explored in BALB/cBy mice using dinitrofluorobenzene (DNFB) and dinitrochlorobenzene (DNCB). A complete dose-response curve was developed for DNFB and the dose which sensitized half the mice in a group (SD50, 0.001%, w/v) was used to test noninvasive enhancement protocols. Several triple-dose protocols tested produced no increase in responsiveness and daily dosing showed a trend toward tolerance induction yielding 20% positive responses. Dietary vitamin A supplementation produced a dramatic enhancement of the responses: ear thickness increase was doubled and the SD50 sensitized 94 to 100% of the mice in the vitamin A groups. We conclude that the MESA allowed identification of ACD potency for known sensitizers at very low concentrations which do not produce ACD with other techniques. The importance of dose-response studies for avoiding the high-dose reduced-response region was also shown. Based on the observation that the vitamin A-augmented MESA was considerably more sensitive than with regular feed, a companion study (P. S. THORNE, C. HAWK, S. D. KALISZEWSKI, P. D. GUINEY, Fundam. Appl. Tox. 17, 807–820, 1991) presents tests of the enhancements to the MESA developed in this work, using weak sensitizers and complex mixtures.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.